L., Goodband, R
Retatrutide, hitting all three receptors, delivered 24.2% in Phase 2 and up to 28.7% in Phase 3
Because research findings depend on study design, model systems, and experimental context, this site does not summarize or interpret study results directly on product pages
Recommended Dosage For Other Indications In Adults The recommended dosage of FARXIGA is 10 mg orally once daily in adults for the following indications: To reduce the risk of sustained eGFR decline, end-stage kidney disease (ESKD), cardiovascular (CV) death, and hospitalization for heart failure (hHF) in patients with chronic kidney disease at risk of progression
There are six GLP-1-based medicines currently approved by the US Food and Drug Administration (FDA): exenatide, lixisenatide, liraglutide, semaglutide, dulaglutide and albiglutide (Table 1)